Literature DB >> 20708064

The role of low-grade inflammation in the polycystic ovary syndrome.

Andrea Repaci1, Alessandra Gambineri, Renato Pasquali.   

Abstract

PCOS is not only the most frequent cause of oligomenorrhea in young women, but also a metabolic disorder characterized by insulin resistance, glucose intolerance, dyslipidemia, and obesity, especially the visceral phenotype. PCOS represents a broad spectrum of endocrine and metabolic alterations which change with age and with increasing adiposity. In fact, during adolescence and youth the predominant clinical manifestations of PCOS are menstrual abnormalities, hirsutism and acne, whereas in peri-menopausal and post-menopausal periods metabolic disorders and an increased risk for cardiovascular diseases prevail. The pathogenetic links between PCOS and metabolic or cardiovascular complications are still debated. However, recent evidence has been focused on a condition of low-grade chronic inflammation as a potential cause of the long-term consequence of the syndrome. In this review we describe the state of low-grade inflammation observed in PCOS. In addition, we hypothesize the potential mechanisms responsible for the generation of this inflammatory state and the role played by low-grade inflammation in linking hyperandrogenism and insulin resistance with the metabolic and cardiovascular long-term complications of the syndrome.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20708064     DOI: 10.1016/j.mce.2010.08.002

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  76 in total

1.  Evaluation of the pro-inflammatory cytokine tumor necrosis factor-α in adolescents with polycystic ovary syndrome.

Authors:  Melissa Pawelczak; Jamie Rosenthal; Sarah Milla; Ying-Hua Liu; Bina Shah
Journal:  J Pediatr Adolesc Gynecol       Date:  2014-09-23       Impact factor: 1.814

2.  Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE).

Authors:  M Caprio; M Infante; E Moriconi; A Armani; A Fabbri; G Mantovani; S Mariani; C Lubrano; E Poggiogalle; S Migliaccio; L M Donini; S Basciani; A Cignarelli; E Conte; G Ceccarini; F Bogazzi; L Cimino; R A Condorelli; S La Vignera; A E Calogero; A Gambineri; L Vignozzi; F Prodam; G Aimaretti; G Linsalata; S Buralli; F Monzani; A Aversa; R Vettor; F Santini; P Vitti; L Gnessi; U Pagotto; F Giorgino; A Colao; A Lenzi
Journal:  J Endocrinol Invest       Date:  2019-05-20       Impact factor: 4.256

3.  Association of VDBP and CYP2R1 gene polymorphisms with vitamin D status in women with polycystic ovarian syndrome: a north Indian study.

Authors:  Deepa Haldar; Nitin Agrawal; Seema Patel; Pankaj Ramrao Kambale; Kanchan Arora; Aditi Sharma; Manish Tripathi; Aruna Batra; Bhaskar C Kabi
Journal:  Eur J Nutr       Date:  2016-12-23       Impact factor: 5.614

4.  Effects of simvastatin and metformin on polycystic ovary syndrome after six months of treatment.

Authors:  Beata Banaszewska; Leszek Pawelczyk; Robert Z Spaczynski; Antoni J Duleba
Journal:  J Clin Endocrinol Metab       Date:  2011-08-24       Impact factor: 5.958

Review 5.  Cardiovascular risk factors and events in women with androgen excess.

Authors:  D Macut; I B Antić; J Bjekić-Macut
Journal:  J Endocrinol Invest       Date:  2014-11-29       Impact factor: 4.256

Review 6.  Childhood obesity and its impact on the development of adolescent PCOS.

Authors:  Amy D Anderson; Christine M Burt Solorzano; Christopher R McCartney
Journal:  Semin Reprod Med       Date:  2014-04-08       Impact factor: 1.303

7.  Immunophenotypic profile of leukocytes in hyperandrogenemic female rat an animal model of polycystic ovary syndrome.

Authors:  Mohadetheh Moulana
Journal:  Life Sci       Date:  2019-01-29       Impact factor: 5.037

Review 8.  Obesity and PCOS: implications for diagnosis and treatment.

Authors:  Richard S Legro
Journal:  Semin Reprod Med       Date:  2012-10-16       Impact factor: 1.303

9.  Dual effects of testosterone in Behcet's disease: implications for a role in disease pathogenesis.

Authors:  S Yavuz; T Akdeniz; V Hancer; M Bicakcigil; M Can; G Yanikkaya-Demirel
Journal:  Genes Immun       Date:  2016-07-28       Impact factor: 2.676

10.  Association of serum pigment epithelium-derived factor with high-sensitivity C-reactive protein in women with polycystic ovary syndrome.

Authors:  Q Cheng; W Xia; S Yang; P Ye; M Mei; Y Song; M Luo; Q Li
Journal:  J Endocrinol Invest       Date:  2013-09       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.